Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (L1): a Dutch multicenter trial

Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions

Nancy F. Olivieri, J. Raymond Buncic, Emily Chew et al. · New England Journal of Medicine · 1986 · 430 citations

Diamond-blackfan Anemia, Hearing Deficit, Health Sciences +14

Clinical Consequences of Acquired Transfusional Iron Overload in Adults

Andrew I. Schafer, Robert G. Cheron, Robert Dluhy et al. · New England Journal of Medicine · 1981 · 301 citations

Heart Failure, Metabolic Disorder, Iron Metabolism +20

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy [see comments]

Doungmo Wakem Yannick Arthur, CE Litz, WJ Miller et al. · Blood · 1994 · 238 citations · Full text

Age‐related incidence and other epidemiological aspects of myelodysplastic syndromes

Carlo Aul, Norbert Gattermann, Wolfgang Schneider · British Journal of Haematology · 1992 · 233 citations

1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD

GeorgeJ. Kontoghiorghes, L Sheppard, M. A. Aldouri et al. · The Lancet · 1987 · 180 citations · Full text

Biochemistry, Iron Metabolism, Medicine +3